Adjuvant dose-dense chemotherapy in breast cancer: a systematic review and meta-analysis of randomized trials. - Wikidata - wikimedia - TriplyDB

Adjuvant dose-dense chemotherapy in breast cancer: a systematic review and meta-analysis of randomized trials.

Adjuvant dose-dense chemotherapy in breast cancer: a systematic review and meta-analysis of randomized trials.

http://www.wikidata.org/entity/Q38445535

about

Dose-Dense Chemotherapy in Metastatic Breast Cancer: Shortening the Time Interval for a Better Therapeutic Index Adjuvant Dose-Dense Chemotherapy in Breast Cancer: Standard of Care in High-Risk Patients Dose intense, dose dense and tailored dose adjuvant chemotherapy for early breast cancer: an evolution of concepts.Adjuvant Capecitabine in Combination With Docetaxel, Epirubicin, and Cyclophosphamide for Early Breast Cancer: The Randomized Clinical FinXX Trial.Recent Advances in the Neoadjuvant Treatment of Breast Cancer.News on the medical treatment of young women with early-stage HER2-negative breast cancer.Dose-dense FEC followed by docetaxel versus docetaxel plus cyclophosphamide as adjuvant chemotherapy in women with HER2-negative, axillary lymph node-positive early breast cancer: a multicenter randomized study by the Hellenic Oncology Research Grou Improved survival for sequentially as opposed to concurrently delivered neoadjuvant chemotherapy in non-metastatic breast cancer.Efficacy, safety and proper dose analysis of PEGylated granulocyte colony-stimulating factor as support for dose-dense adjuvant chemotherapy in node positive Chinese breast cancer patients.Assessing the Clinical Benefit of Systemic Adjuvant Therapies for Early Breast Cancer.Long-term safety and survival outcomes from the Scandinavian Breast Group 2004-1 randomized phase II trial of tailored dose-dense adjuvant chemotherapy for early breast cancer.Neoadjuvant treatments in triple-negative breast cancer patients: where we are now and where we are going.Biology, staging, and treatment of breast cancer during pregnancy: reassessing the evidences.Survival benefit of pure dose-dense chemotherapy in breast cancer: a meta-analysis of randomized controlled trials.

P2860

Q26751245-6DBD92AA-9A1D-409B-BF9E-303465239617 Q26751253-44CCD233-8751-49B1-A18E-4FEB80F7695A Q36379148-4FFA862D-F1D0-437E-8A1B-0FD34AAE68CD Q38380059-5CE382D3-3189-4E85-B906-FD328E3062C6 Q38687392-2F666EA0-1EE4-4A0A-8C3F-42491100DA5F Q38870541-59AF2AB6-478D-4339-AA45-E3B5F8D486DA Q40093604-E0B51604-EFA0-43F7-A99A-8218C3533200 Q42113569-A46DD3D2-61D2-4325-AD6D-43DDD6E56535 Q44834419-2A437ABC-A176-4A1D-85C2-EDAA3A56B28D Q47138534-FF007F5C-D10B-4337-A027-BAFC07271136 Q47391721-1ABAF580-7928-4206-A5DF-5E95FC9CAB9E Q49303842-8BE8E788-3EEC-4874-A13D-4C4F769A12DC Q55142706-BB7D1551-A0FB-48F7-A27B-9B23EDBF87C3 Q55711832-7FD27D6F-EF51-4A5E-92C0-9C9C533BDBCB

P2860

Adjuvant dose-dense chemotherapy in breast cancer: a systematic review and meta-analysis of randomized trials.

http://www.wikidata.org/entity/Q38445535

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Adjuvant dose-dense chemothera ...... analysis of randomized trials.

@en

type

label

Adjuvant dose-dense chemothera ...... analysis of randomized trials.

@en

prefLabel

Adjuvant dose-dense chemothera ...... analysis of randomized trials.

@en

P1433

Q38445535-C09DD522-4D73-4929-B2DE-A7D079B83E5A

P1476

Q38445535-FBD4CB1F-2F16-40B0-89FD-8D22F6A09835

P2093

Q38445535-16A3EBDC-BBC6-4E0D-8585-DE4F38496EDF

Q38445535-3907E91F-7A0C-40F8-BB5D-2BE5C5CD3305

Q38445535-470112FD-E62F-4AAE-8C84-8EB7FEE4F81D

Q38445535-6BE330CE-960A-4498-AC0A-051FE571CABB

Q38445535-7C81623B-113D-4DF2-9B27-5FBEB99F0B04

Q38445535-E2F0E0B0-2386-4A81-A7F8-A24C2C036664

Q38445535-ED833945-792B-4769-9F05-8F3A7D4863B5

P2860

Q38445535-0907E6CD-3ED4-48A5-BA88-5843E92249D8

Q38445535-1445FB5C-F192-4A12-9DE9-53E463FB3187

Q38445535-1DB42A67-E22B-4513-8BBF-DC273945F1A7

Q38445535-2C643348-211B-4E78-8AB7-A55B906867BF

Q38445535-3615015F-8AF5-4503-9972-C7D058B67FA5

Q38445535-3FDF11D7-9BDE-4CB0-9F6C-D43ED6BFC5D0

Q38445535-4C286023-D254-4984-8591-82FA199C5CA5

Q38445535-4C87ADEE-EA48-4D79-AFC6-4F8E72A9C142

Q38445535-51D65650-94EF-4162-9E2E-173C2F32972D

Q38445535-611DDD89-E193-4C9F-B0B3-BD8CB4E2A2A6

P2888

Q38445535-B9C74A52-EEE5-4F9D-A456-56D478E7C678

P304

Q38445535-ED9292E0-C075-4906-98AC-D82BB8AE1857

P31

Q38445535-18161BE4-379F-4BD6-97C8-27C913354188

Q38445535-672c89c5-de20-4494-96d9-7cef7c254e52

P356

Q38445535-B7D1314E-EAFD-4C7C-94A3-97D4C5D0A7C0

P407

Q38445535-1D68E353-70D3-4D8E-91A7-95B8B63F4941

P433

Q38445535-7BF247C9-4116-478D-BFC0-BD66EB83925A

P478

Q38445535-90CD730B-B5F7-4FF8-BC8B-05FD2EB77C77

P577

Q38445535-AC6045C7-4177-4C37-8DB5-F11D29F30C09

P6179

Q38445535-C3741C4C-629A-408A-A181-A80DC861B18F

P698

Q38445535-DEE21650-6A35-4561-B33F-89FDDA7DC3A4

P356

S10549-015-3405-4

P1433

Breast Cancer Research and Treatment

P1476

Adjuvant dose-dense chemothera ...... analysis of randomized trials.

@en

P2093

Andrea Coinu

http://www.w3.org/2001/XMLSchema#string

Fausto Petrelli

http://www.w3.org/2001/XMLSchema#string

Karen Borgonovo

http://www.w3.org/2001/XMLSchema#string

Mara Ghilardi

http://www.w3.org/2001/XMLSchema#string

Mary Cabiddu

http://www.w3.org/2001/XMLSchema#string

Sandro Barni

http://www.w3.org/2001/XMLSchema#string

Veronica Lonati

http://www.w3.org/2001/XMLSchema#string

P2860

Bias in meta-analysis detected by a simple, graphical test

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

Operating characteristics of a rank correlation test for publication bias

Meta-analysis in clinical trials

Dose-dense adjuvant chemotherapy in early breast cancer patients: results from a randomized trial.

Cyclophosphamide, epirubicin, and Fluorouracil versus dose-dense epirubicin and cyclophosphamide followed by Paclitaxel versus Doxorubicin and cyclophosphamide followed by Paclitaxel in node-positive or high-risk node-negative breast cancer

Intense dose-dense sequential chemotherapy with epirubicin, paclitaxel, and cyclophosphamide compared with conventionally scheduled chemotherapy in high-risk primary breast cancer: mature results of an AGO phase III study.

Dose-dense chemotherapy in nonmetastatic breast cancer: a systematic review and meta-analysis of randomized controlled trials.

High-dose chemotherapy with autologous stem-cell support as adjuvant therapy in breast cancer: overview of 15 randomized trials.

Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials

P2888

s10549-015-3405-4

P304

251-259

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10549-015-3405-4

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

151

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1002828992

http://www.w3.org/2001/XMLSchema#string

P698

25917869

http://www.w3.org/2001/XMLSchema#string